Vidavo S.A. engages in the design, development, and provision of digital health solutions. The company offers Vida24, a modular telemedicine solution transforming primary healthcare through digital services and automation. It offers digital health solutions, including telemedicine and care solutions, wellness and preventive health, smart health systems, and strategic advisory services. The company was founded in 2002 and is headquartered in Thessaloniki, Greece.…
Vidavo (ATH: VIDAVO) is listed on Athens Exchange, where its shares trade in EUR. It belongs to the Health Information Services industry, part of the Healthcare sector, and reports about 16 employees.
The shares were at 8.550 EUR on 19 November 2026, up 64.4% over 52 weeks. Its 52-week range is 5.250 EUR to 11.50 EUR: the price is 25.7% below the high and 62.9% above the low.
At a market capitalisation of 8.91M EUR, it trades at 6.8 times trailing earnings. The median trailing P/E of its 15 largest Health Information Services peers is 39.9, a discount of 83% for VIDAVO.
Vidavo reports return on equity of 32.7% and an operating margin of 40.6%.
It holds more cash than debt, a net cash position of 1.31M EUR. Its Piotroski F-score is 5 out of 9, an average reading of its financial health.
No upcoming events tracked.